Stereotaxis Reports 2018 First Quarter Financial Results
Stereotaxis, Inc. (STXS)
US:NASDAQ Investor Relations:
ir.stereotaxis.com
Company Research
Source: GlobeNewswire
3% year-over-year growth in recurring revenueContinued progress on strategic innovation initiatives; collaboration with Acutus MedicalIncreasing quantity and quality of peer-reviewed clinical validationStrong financial position to reach profitability without the need for additional financingsConference call today at 10:00 a.m. Eastern Time ST. LOUIS, May 14, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the first quarter ended March 31, 2018. “We continue to improve our commercial execution, advance our strategic innovation initiatives, add to the robust body of clinical literature supporting our technology, and do all this while being financially disciplined and attentive to shareholder value,” said David Fischel, Chairman and CEO. “The positive recent trend of recurring revenue growth continued in the first quarter. Our commercial focus
Show less
Read more
Impact Snapshot
Event Time:
STXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STXS alerts
High impacting Stereotaxis, Inc. news events
Weekly update
A roundup of the hottest topics
STXS
News
- Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months [Seeking Alpha]Seeking Alpha
- Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter [Yahoo! Finance]Yahoo! Finance
- Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Stereotaxis Inc (STXS) Faces Revenue Pressure Amid Strategic Transformation [Yahoo! Finance]Yahoo! Finance
- Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States [Yahoo! Finance]Yahoo! Finance
STXS
Earnings
- 3/4/24 - Miss
STXS
Sec Filings
- 4/8/24 - Form DEFA14A
- 4/4/24 - Form 4
- 4/4/24 - Form DEFA14A
- STXS's page on the SEC website